Recent research has identified genetic mutations contributing to MPNST pathogenesis, especially alterations in NF1, CDKN2A, and components of the PRC2, including EED, EZH2, and SUZ12. This evidence concerns the gene EZH2 and malignant peripheral nerve sheath tumor.